Todd Berard - 14 Oct 2021 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
Chief Marketing Officer
Signature
/s/ Todd C.J. Berard
Issuer symbol
BLFS
Transactions as of
14 Oct 2021
Net transactions value
-$512,451
Form type
4
Filing time
18 Oct 2021, 20:30:33 UTC
Previous filing
30 Sep 2021
Next filing
17 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Sale $35,728 -895 -1.1% $39.92 77,664 14 Oct 2021 Direct F1
transaction BLFS Common Stock Options Exercise $10,102 +6,160 +7.9% $1.64* 83,824 14 Oct 2021 Direct
transaction BLFS Common Stock Sale $245,846 -6,160 -7.3% $39.91 77,664 14 Oct 2021 Direct F2, F3
transaction BLFS Common Stock Options Exercise $10,102 +6,160 +7.9% $1.64* 83,824 15 Oct 2021 Direct
transaction BLFS Common Stock Sale $251,082 -6,160 -7.3% $40.76 77,664 15 Oct 2021 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLFS Stock Option (Right to Buy) Options Exercise $0 -6,160 -25% $0.000000 18,480 14 Oct 2021 Common Stock 6,160 $1.64 Direct F5
transaction BLFS Stock Option (Right to Buy) Options Exercise $0 -6,160 -33% $0.000000 12,320 15 Oct 2021 Common Stock 6,160 $1.64 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.48 to $40.17, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.70 to $41.54, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 On December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.